Skip to Main Content

Author Details

Albrecht von Brunn
Max-von-Pettenkofer Institute, Ludwig-Maximilians-University (LMU) Munich
1983
50
28
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36323154Corrigendum to 'Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506' Virus Research (2012) 165/1 [112-117]: Corrigendum.Virus Res2023
35303071Soluble uric acid inhibits β2 integrin-mediated neutrophil recruitment in innate immunity.Blood2022
36211973Effects of immunophilin inhibitors and non-immunosuppressive analogs on coronavirus replication in human infection models.Front Cell Infect Microbiol2022
34869443Discrimination of SARS-CoV-2 Infections From Other Viral Respiratory Infections by Scent Detection Dogs.Front Med (Lausanne)2021
33876849The SARS-unique domain (SUD) of SARS-CoV and SARS-CoV-2 interacts with human Paip1 to enhance viral RNA translation.EMBO J2021
32274649SARS-CoV-2 and Europe: timing of containment measures for outbreak control.Infection2020
34765991Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein.Mol Biomed2020
31634494Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication.Antiviral Res2020
32045235α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment.J Med Chem2020
32777170Cyclosporine and COVID-19: Risk or favorable?Am J Transplant2020
32835213Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19.Med Drug Discov2020
30597184Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018.Antiviral Res2019
27519799p53 down-regulates SARS coronavirus replication and is targeted by the SARS-unique domain and PLpro via E3 ubiquitin ligase RCHY1.Proc Natl Acad Sci U S A2016
27479465Tubulins interact with porcine and human S proteins of the genus Alphacoronavirus and support successful assembly and release of infectious viral particles.Virology2016
26318518Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for Human Coronavirus 229E replication.Curr Opin Virol2015
26320757Editorial overview: Engineering for viral resistance.Curr Opin Virol2015
24566223Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir.Virus Res2014
23596286Comprehensive analysis of varicella-zoster virus proteins using a new monoclonal antibody collection.J Virol2013
22130999Yeast two-hybrid screens: improvement of array-based screening results by N- and C-terminally tagged fusion proteins.Methods Mol Biol2012
23057872Virus-host interactomes--antiviral drug discovery.Curr Opin Virol2012
22748812Bacteriophage protein-protein interactions.Adv Virus Res2012
22349148Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506.Virus Res2012
21539810Crystal structure of the middle domain of human poly(A)-binding protein-interacting protein 1.Biochem Biophys Res Commun2011
22046132The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors.PLoS Pathog2011
19730696Evolutionarily conserved herpesviral protein interaction networks.PLoS Pathog2009
17520018Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome.PLoS One2007
15969685Mutations in the high-affinity IgE receptor beta-chain are not associated with nonresponder status.Allergy2005
10782994Polyhistidine-tagged hepatitis B core particles as carriers of HIV-1/gp120 epitopes of different HIV-1 subtypes.Biol Chem2000
10092142Purification of E. coli-expressed HIS-tagged hepatitis B core antigen by Ni2+ -chelate affinity chromatography.J Virol Methods1999
10373359Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein.J Mol Biol1999
9310933Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland.J Viral Hepat1997
9174569Is codon 129 of prion protein polymorphic in human beings but not in animals?Lancet1997
7734191New crown motif of an HIV-1 V3 loop sequence from a Ugandan AIDS patient.AIDS Res Hum Retroviruses1995
8679289Genetically engineered HIV type 1 peptides as tools for the determination of anti-V3 loop antibody titers in sera from HIV type 1-infected patients.AIDS Res Hum Retroviruses1995
8554912Analysis of the V3 loop sequences from 10 HIV type 1-infected AIDS patients from Paraguay.AIDS Res Hum Retroviruses1995
8107219A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.J Virol1994
8133071Characterization of metabolically labelled antigen following immunoprecipitation with antibody bound on ELISA plates.J Immunol Methods1994
7689283Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.Vaccine1993
1456888Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.Arch Virol1992
1731104Replication of parvovirus B19 in hematopoietic progenitor cells generated in vitro from normal human peripheral blood.J Virol1992
1456889Immunological reactivity of a human immunodeficiency virus type I derived peptide representing a consensus sequence of the GP120 major neutralizing region V3.Arch Virol1992
1520981Heat stability of parvovirus B19: kinetics of inactivation.Zentralbl Bakteriol1992
1654995Productive infection of in vitro generated haemopoietic progenitor cells from normal human adult peripheral blood with parvovirus B19: studies by morphology, immunocytochemistry, flow-cytometry and DNA-hybridization.Br J Haematol1991
1846347Antibodies in anti-HBe-positive patient sera bind to an HBe protein expressed on the cell surface of human hepatoma cells: implications for virus clearance.Hepatology1991
1716808Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite.Vaccine1991
1656954Production of 22 nm HBsAG particles by human lymphocytes infected with a recombinant vaccinia virus containing the coding sequence for hepatitis B virus surface antigen.Biochem Biophys Res Commun1991
1711125Recombinant peripheral myelin protein P0 confers both adhesion and neurite outgrowth-promoting properties.J Neurosci Res1990
2680981Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum.Infect Immun1989
3956873Transient synthesis of a specific set of proteins during the rapid cleavage phase of sea urchin development.Dev Biol1986
6653880Photoreversible inhibition by ultraviolet light of germ line development in Smittia sp. (Chironomidae, Diptera).Dev Biol1983
  • 1 - 50 of 50

Recommended Authors

Gladstone Institutes
Career Start Year 2016
Number of shared co-authors 1
Washington University School of Medicine in St. Louis
Career Start Year 2015
Number of shared co-authors 0
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 3
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Institute of Tropical Medicine
Career Start Year 2007
Number of shared co-authors 1
Goethe University Frankfurt, University Hospital, Institute for Medical Virology
Career Start Year 2004
Number of shared co-authors 1
Texas Biomedical Research Institute
Career Start Year 2001
Number of shared co-authors 1
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 1
Gilead Sciences Inc.
Career Start Year 1997
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1997
Number of shared co-authors 1
University of Cambridge
Career Start Year 1996
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1995
Number of shared co-authors 0
Icahn School of Medicine at Mount Sinai
Career Start Year 1994
Number of shared co-authors 0
The Rockefeller University
Career Start Year 1993
Number of shared co-authors 1
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 1
Yale University School of Medicine
Career Start Year 1993
Number of shared co-authors 0
Institute of Virology, Philipps University Marburg
Career Start Year 1992
Number of shared co-authors 1
Institute of Virology, Medical Center - University of Freiburg
Career Start Year 1989
Number of shared co-authors 1
MRC-University of Glasgow Centre for Virus Research
Career Start Year 1987
Number of shared co-authors 1
Regeneron Pharmaceuticals, Inc.
Career Start Year 1987
Number of shared co-authors 0
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 2
Ben-Gurion University of the Negev
Career Start Year 1984
Number of shared co-authors 0
Max-Planck-Institut fur Entwicklungsbiologie
Career Start Year 1984
Number of shared co-authors 0
University of Texas Medical Branch
Career Start Year 1983
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1982
Number of shared co-authors 0
Rockefeller University
Career Start Year 1981
Number of shared co-authors 2
University of Oxford
Career Start Year 1976
Number of shared co-authors 1
Institute of Nuclear Sciences VINCA
Career Start Year 1976
Number of shared co-authors 0
Tulane University School of Medicine
Career Start Year 1974
Number of shared co-authors 0
Campus Universidad Autonoma de Madrid
Career Start Year 1971
Number of shared co-authors 1

Collaborators

Ludwig-Maximilians-Universitat Munchen
Co-authored papers 4
University of Edinburgh
Co-authored papers 4
Institute of Informatics, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 3
University Clinic for Swine, University of Veterinary Medicine Vienna
Co-authored papers 3
Center for the Study of Biological Complexity, Virginia Commonwealth University
Co-authored papers 3
Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB
Co-authored papers 2
SSSSGerman Cancer Research Center
Co-authored papers 2
Center for Biomedical Education and Research (ZBAF), Witten/Herdecke University
Co-authored papers 2
Heidelberg University Biochemistry Center
Co-authored papers 2
University Hospital of the Ludwig Maximilians University Munich
Co-authored papers 2
Oslo University Hospital
Co-authored papers 1
Saarland University
Co-authored papers 1
The University of Alabama at Birmingham
Co-authored papers 1
University of Munich
Co-authored papers 1
University of California San Francisco
Co-authored papers 1
Vanderbilt University Medical Center
Co-authored papers 1
Co-authored papers 1
Stanford Center for Biomedical Informatics Research, Stanford University
Co-authored papers 1
Germany Institute of Systems Biology, Shanghai University
Co-authored papers 1
Boehringer Ingelheim RCV GmbH & Co. KG
Co-authored papers 1
University of Pennsylvania.
Co-authored papers 1
university of california los angeles
Co-authored papers 1
Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
UCD Conway Institute of Biomolecular and Biomedical Science
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of North Carolina
Co-authored papers 1
Co-authored papers 1